Altria Q1 2026: Adjusted EPS of $1.32 Beats Expectations
Altria Group reported Q1 2026 net revenues of $5.43 billion, up 3.2% year-over-year, with adjusted EPS of $1.32 exceeding consensus by $0.07. The company reaffirmed full-year adjusted EPS guidance of $5.56–$5.72.
- Altria posted Q1 2026 adjusted EPS of $1.32, beating estimates by $0.07 on $5.43B revenue growth
- The company reaffirmed full-year EPS guidance of $5.56–$5.72, up 2.5–5.5% from 2025
MOFrequently Asked Questions
Why does Altria's adjusted EPS differ from GAAP EPS?
GAAP EPS is calculated using standard accounting principles, while adjusted EPS excludes one-time charges such as goodwill impairments and litigation costs. In Q1 2026, adjusted EPS was $1.32 versus GAAP EPS of $1.30. In Q1 2025, a $873 million non-cash e-vapor goodwill impairment depressed GAAP EPS to $0.63, highlighting the significance of excluding such items for operational comparison.
Why can't Altria sell NJOY ACE?
The U.S. International Trade Commission (ITC) issued an import ban and sales suspension order for NJOY ACE products. Altria does not expect the product to return to the U.S. market during 2026.
How much did Altria return to shareholders in Q1?
The company paid $1.8 billion in dividends during Q1. Additionally, it repurchased 4.5 million shares for $280 million at an average price of $62.33 per share. Altria has $720 million remaining under its $2 billion share repurchase authorization, which expires December 31, 2026.
What is Altria's full-year 2026 earnings outlook?
Altria projects 2026 full-year adjusted EPS of $5.56–$5.72, representing 2.5–5.5% growth versus 2025's baseline of $5.42 per share. This guidance incorporates slowing e-vapor market growth and macroeconomic headwinds.
Smart Money Briefing
Weekly summaries of Wall Street guru moves and crypto whale activity.


